Literature DB >> 17158931

Mouse mutants reveal that putative protein interaction sites in the p53 proline-rich domain are dispensable for tumor suppression.

Franck Toledo1, Crystal J Lee, Kurt A Krummel, Luo-Wei Rodewald, Chung-Wen Liu, Geoffrey M Wahl.   

Abstract

The stability and activity of tumor suppressor p53 are tightly regulated and partially depend on the p53 proline-rich domain (PRD). We recently analyzed mice expressing p53 with a deletion of the PRD (p53(DeltaP)). p53(DeltaP), a weak transactivator hypersensitive to Mdm2-mediated degradation, is unable to suppress oncogene-induced tumors. This phenotype could result from the loss of two motifs: Pin1 sites proposed to influence p53 stabilization and PXXP motifs proposed to mediate protein interactions. We investigated the importance of these motifs by generating mice encoding point mutations in the PRD. p53(TTAA) contains mutations suppressing all putative Pin1 sites in the PRD, while p53(AXXA) lacks PXXP motifs but retains one intact Pin1 site. Both mutant proteins accumulated in response to DNA damage, although the accumulation of p53(TTAA) was partially impaired. Importantly, p53(TTAA) and p53(AXXA) are efficient transactivators and potent suppressors of oncogene-induced tumors. Thus, Pin1 sites in the PRD may modulate p53 stability but do not significantly affect function. In addition, PXXP motifs are not essential, but structure dictated by the presence of prolines, PXXXXP motifs that may mediate protein interactions, and/or the length of this region appears to be functionally significant. These results may explain why the sequence of the p53 PRD is so variable in evolution.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17158931      PMCID: PMC1800716          DOI: 10.1128/MCB.00999-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells.

Authors:  Nicole Baptiste; Philip Friedlander; Xinbin Chen; Carol Prives
Journal:  Oncogene       Date:  2002-01-03       Impact factor: 9.867

2.  Stress-induced p53 runs a direct mitochondrial death program: its role in physiologic and pathophysiologic stress responses in vivo.

Authors:  Susan Erster; Ute M Moll
Journal:  Cell Cycle       Date:  2004-12-18       Impact factor: 4.534

3.  PUMA couples the nuclear and cytoplasmic proapoptotic function of p53.

Authors:  Jerry E Chipuk; Lisa Bouchier-Hayes; Tomomi Kuwana; Donald D Newmeyer; Douglas R Green
Journal:  Science       Date:  2005-09-09       Impact factor: 47.728

4.  Mutations in proline 82 of p53 impair its activation by Pin1 and Chk2 in response to DNA damage.

Authors:  Michael Berger; Nathalie Stahl; Giannino Del Sal; Ygal Haupt
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

5.  The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression.

Authors:  C Venot; M Maratrat; C Dureuil; E Conseiller; L Bracco; L Debussche
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

6.  The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation.

Authors:  Kurt A Krummel; Crystal J Lee; Franck Toledo; Geoffrey M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

Review 7.  Phosphorylation-specific prolyl isomerization: is there an underlying theme?

Authors:  Gerburg Wulf; Greg Finn; Futoshi Suizu; Kun Ping Lu
Journal:  Nat Cell Biol       Date:  2005-05       Impact factor: 28.824

8.  Guinea pig p53 mRNA: identification of new elements in coding and untranslated regions and their functional and evolutionary implications.

Authors:  A M D'erchia; G Pesole; A Tullo; C Saccone; E Sbisà
Journal:  Genomics       Date:  1999-05-15       Impact factor: 5.736

9.  Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity.

Authors:  J Zhu; J Jiang; W Zhou; K Zhu; X Chen
Journal:  Oncogene       Date:  1999-03-25       Impact factor: 9.867

10.  Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism.

Authors:  M B Yaffe; M Schutkowski; M Shen; X Z Zhou; P T Stukenberg; J U Rahfeld; J Xu; J Kuang; M W Kirschner; G Fischer; L C Cantley; K P Lu
Journal:  Science       Date:  1997-12-12       Impact factor: 47.728

View more
  23 in total

Review 1.  Posttranslational modification of p53: cooperative integrators of function.

Authors:  David W Meek; Carl W Anderson
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-28       Impact factor: 10.005

Review 2.  p53 at a glance.

Authors:  Colleen A Brady; Laura D Attardi
Journal:  J Cell Sci       Date:  2010-08-01       Impact factor: 5.285

3.  Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain.

Authors:  Mark Wells; Henning Tidow; Trevor J Rutherford; Phineus Markwick; Malene Ringkjobing Jensen; Efstratios Mylonas; Dmitri I Svergun; Martin Blackledge; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-07       Impact factor: 11.205

Review 4.  Prolyl isomerase Pin1 in cancer.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Cell Res       Date:  2014-08-15       Impact factor: 25.617

5.  The proline rich domain of p53 is dispensable for MGMT-dependent DNA repair and cell survival following alkylation damage.

Authors:  Katherine Baran; Mao Yang; Christopher P Dillon; Leona L Samson; Douglas R Green
Journal:  Cell Death Differ       Date:  2017-07-28       Impact factor: 15.828

Review 6.  Illuminating p53 function in cancer with genetically engineered mouse models.

Authors:  Patty B Garcia; Laura D Attardi
Journal:  Semin Cell Dev Biol       Date:  2014-01-03       Impact factor: 7.727

Review 7.  Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins.

Authors:  Yih-Cherng Liou; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Trends Biochem Sci       Date:  2011-08-17       Impact factor: 13.807

8.  p53 Amino-terminus region (1-125) stabilizes and restores heat denatured p53 wild phenotype.

Authors:  Anuj Kumar Sharma; Amjad Ali; Rajan Gogna; Amir Kumar Singh; Uttam Pati
Journal:  PLoS One       Date:  2009-10-22       Impact factor: 3.240

Review 9.  MDM2 and MDM4: p53 regulators as targets in anticancer therapy.

Authors:  Franck Toledo; Geoffrey M Wahl
Journal:  Int J Biochem Cell Biol       Date:  2007-04-08       Impact factor: 5.085

Review 10.  In vivo analysis of p53 tumor suppressor function using genetically engineered mouse models.

Authors:  Daniela Kenzelmann Broz; Laura D Attardi
Journal:  Carcinogenesis       Date:  2010-01-22       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.